These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25043743)

  • 21. United States trends in thrombolysis for older adults with acute ischemic stroke.
    George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
    Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital].
    Figueroa-Reyes T; Sáez M D; Mansilla L E; Sánchez V R; Nogales-Gaete J; Delgado B I
    Rev Med Chil; 2011 Sep; 139(9):1118-27. PubMed ID: 22215389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
    Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
    Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.
    Abilleira S; Ribera A; Dávalos A; Ribó M; Chamorro A; Cardona P; Molina CA; Martínez-Yélamos A; Urra X; Dorado L; Roquer J; Martí-Fàbregas J; Aja L; Tomasello A; Castaño C; Blasco J; Cánovas D; Castellanos M; Krupinski J; Guimaraens L; Perendreu J; Ustrell X; Purroy F; Gómez-Choco M; Baiges JJ; Cocho D; Saura J; Gallofré M;
    Cerebrovasc Dis; 2014; 38(5):328-36. PubMed ID: 25428822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute ischemic stroke and thrombolysis location: comparing telemedicine and stroke center treatment outcomes.
    Ionita CC; Sharma J; Janicke DM; Levy EI; Siddiqui AH; Agrawal S; Baker JG; Agopian E; Olson K; Hopkins LN
    Hosp Pract (1995); 2009 Dec; 37(1):33-9. PubMed ID: 20877169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion.
    Ricciardi AC; López-Cancio E; Pérez de la Ossa N; Sobrino T; Hernández-Pérez M; Gomis M; Munuera J; Muñoz L; Dorado L; Millán M; Dávalos A; Arenillas JF
    Cerebrovasc Dis; 2014; 37(4):304-11. PubMed ID: 24851928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002.
    Bateman BT; Schumacher HC; Boden-Albala B; Berman MF; Mohr JP; Sacco RL; Pile-Spellman J
    Stroke; 2006 Feb; 37(2):440-6. PubMed ID: 16397164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T; Kato T; Sakai H; Nishimura Y
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
    Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
    Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population.
    Kim JT; Fonarow GC; Smith EE; Reeves MJ; Navalkele DD; Grotta JC; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Saver JL
    Circulation; 2017 Jan; 135(2):128-139. PubMed ID: 27815374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator.
    Meiner Z; Sajin A; Schwartz I; Tsenter J; Yovchev I; Eichel R; Ben-Hur T; Leker RR
    PM R; 2010 Aug; 2(8):698-702; quiz 792. PubMed ID: 20709299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.